<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-68632</identifier>
<setSpec>1139-6202</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">Introduction. The main purpose was to analyze the increase of the ambulatory pharmaceutical cost for the health systems in Argentina as a result of the Ministerial resolution Nº 310/04, that increase went up from 40% to 70% the pharmaceutical cover of chronic patients and it established a reference prices system. Methods. Two systems of health were analyzed: "A" with basic cover and "B" with extended cover, by means of a model of reassignment of real consumptions in relation to the last quarter of 2003. Results. Our results showed significant increases in the net costs: 49% and 24.4% for the systems "A" and "B" respectively. Using an analysis of sensibility it was verified that an increased of 10.2% in the received discounts by system "A" cancelled the augment in its cost. The same effect was observed in the system "B" just for an increase of 3.8% in the same discounts. Using the strategy to eliminate the cover of the products which were excluded by the new normative, only the system "B" could eliminate the greatest costs, because it was considered a 47.5% partial discount of the waste in this products. Nevertheless, the model tends to produce positive results in health because it provides the access of the chronic patient to the medicine by means of the decrease of its pocket expense (AU)</dc:description>
<dc:creator>Filinger, Ester</dc:creator>
<dc:creator>Rodríguez, Claudio</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introduccion. El objetivo del estudio es analizar el incremento del costo farmacéutico ambulatorio para los sistemas de salud en Argentina como consecuencia de la Resolución ministerial nº 310/04 que llevó del 40% al 70% la cobertura farmacéutica de pacientes crónicos e implantó un sistema de precios de referencia. Métodos. Se analizaron dos sistemas de salud "A" con cobertura básica y "B" con una cobertura amplia, mediante un modelo de reasignación de consumos reales correspondientes al último trimestre de 2003. Resultados. Nuestros resultados muestran significativos aumentos en los costos netos, del 49,0% para el sistema "A" y del 24,4% para "B". Mediante un análisis de sensibilidad se verificó que un aumento del 10,2% de las bonificaciones recibidas por &#147;A&#148; anulaba el incremento en sus costos. El mismo efecto se observó en el sistema &#147;B&#148;, tan sólo con un aumento del 3,8% en las citadas bonificaciones. Utilizando la estrategia de suprimir la cobertura de los productos no incluidos en la Resolución, sólo el sistema &#147;B&#148; pudo anular los mayores costos, aplicando una restricción parcial del 47,5% en el gasto sobre estos productos. Sin embargo, el modelo tiende a producir resultados positivos en salud al facilitar el acceso del paciente crónico al medicamento mediante la disminución de su gasto de bolsillo (AU)</dc:description>
<dc:source>Pharm. care Esp;7(3): 106-114, jul.-sept. 2005. ilus, tab</dc:source>
<dc:identifier>ibc-68632</dc:identifier>
<dc:subject>^d23106^s22018</dc:subject>
<dc:subject>^d3709^s22018</dc:subject>
<dc:subject>^d16855^s22018</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28563^s22018</dc:subject>
<dc:subject>^d1121</dc:subject>
<dc:type>article</dc:type>
<dc:date>200509</dc:date>
</metadata>
</record>
</ibecs-document>
